Screener
Bio-Techne TECH Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
Based on trailing twelve months.
The source filing: Bio-Techne’s 10-Q, filed May 8, 2025. Open the filing →
- Filed
- May 8, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q1 2025
- Accession
- 0001558370-25-006990
FAQ
- What is Bio-Techne's return on equity?
- Bio-Techne (TECH) reported return on equity of 6.5% in Q1 2025.
- How has Bio-Techne's return on equity changed year-over-year?
- Bio-Techne's return on equity decreased by 37.2% year-over-year, from 10.4% to 6.5%.
- What is the long-term trend for Bio-Techne's return on equity?
- Over 2 years (2022 to 2024), Bio-Techne's return on equity has grown at a -29.3% compound annual growth rate (CAGR), from 16.7% to 8.3%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Bio-Techne's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude